pSivida diabetic macular edema trials to proceed

Perth-based biotechnology company pSivida Ltd will complete the third phase of trials of its diabetic macular edema treatment Medidur without change after an independent Data Safety Monitoring Board recommended it go ahead.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer